CTSS and cancer: Abundant evidence has been presented on the upregulation of cathepsins in cancer, and that the presence of increased cathepsin activity is correlated with malignant progression and poor prognosis of patients with breast, lung, colorectal cancer, and many other types of cancer [21,25–28].